Notification of managers' transactions
13 Mayo 2024 - 4:05AM
Notification of managers' transactions
ANNOUNCEMENT NO. 263
Notification of managers’
transactions
ChemoMetec A/S has received the enclosed
notification pursuant to Article 19 of EU Regulation no. 596/2014
of transactions related to shares in ChemoMetec A/S made by persons
discharging managerial responsibilities in ChemoMetec A/S and/or
persons closely associated with them.
See the transactions of CEO Martin Helbo Behrens in
the attached PDF document.
For further information, please contact:
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For further information, go to
www.chemometec.com.
- 2024-05-13 Martin Helbo Behrens Notification
Chemometec AS (TG:CHY)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Chemometec AS (TG:CHY)
Gráfica de Acción Histórica
De May 2023 a May 2024